Mark D. Trone

home / authors / mark-d-trone

Articles

Evaluating Progress in Analytical Quality by Design

Evaluating Progress in Analytical Quality by Design

Elizabeth Hewitt;Andy Rignall;Mark D. Trone;Patrick Jackson;Marion Chatfield;Mark Argentine;Qinggang Wang;Shreekant Karmarkar;Andrea M. Pless;Zeena Williams;Kimber Barnett;David Semin;Yanqun Zhao;Ariane Marolewski
April 2nd 2017

The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.

Part VII GMPs for Small Molecule Drugs in Early Development Workshop Summary

Part VII GMPs for Small Molecule Drugs in Early Development Workshop Summary

Q. Chan Li;Mark D. Trone;Jackson Pellett;Michael Szulc;Kirby Wong-Moon
December 2nd 2014

The authors explore and define common industry approaches and practices when applying GMPs in early development.

GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VI

GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VI

Q. Chan Li;Mark D. Trone;Jackson Pellett;Michael Szulc;Kirby Wong-Moon
November 2nd 2014

The authors explore and define common industry approaches and practices when applying GMPs in early development.

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

Dennis O'Connor;James S. McElvain;Mark D. Trone;Michael Coutant;Michael Szulc;Mehran Yazdanian;Shuhong Zhang;Scott A. Miller;Peter Yehl;Kirby Wong-Moon;Zhihong Ge;Frank Swanek
October 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

GMPs for Method Validation in Early Development: An Industry Perspective (Part II)

GMPs for Method Validation in Early Development: An Industry Perspective (Part II)

Brent Kleintop;Mark D. Trone;Michael Szulc;Donald Chambers;Kristin Patterson;Gary Guo;Henrik Rasmussen;Steve Deegan;John Spicuzza;Steven Nowak;Zhanna Yuabova;Karla Tombaugh
July 2nd 2012

IQ Consortium representatives explore industry approaches for applying GMPs in early development.

Latest Updated Articles

Document Review and Quality Control Concept. Document with a checkmark, quality assurance, and process control. auditing, compliance, verification, data inspection, and business workflow management. | Image Credit: © Supatman - stock.adobe.com
Published: July 4th 2025 | Updated: August 28th 2025
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
Published: April 21st 2025 | Updated: June 17th 2025
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com
Published: February 4th 2025 | Updated: March 3rd 2025
Advancing ADCs to the Next Level
CPHI Milan 2024: New Developments in ADC Technologies
Published: October 10th 2024 | Updated: March 3rd 2025
CPHI Milan 2024: New Developments in ADC Technologies
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com
Published: January 10th 2025 | Updated: January 13th 2025
Cavazzoni Retires as CDER Director
Buy, Sell, Hold: Cell and Gene Therapy
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
© 2025 MJH Life Sciences

All rights reserved.